Kronos Bio, Inc. Impairment Lessor Asset Under Operating Lease
Kronos Bio, Inc. reported Impairment Lessor Asset Under Operating Lease of $2.30 million for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-13.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ImpairmentLessorAssetUnderOperatingLease · last filed 2023-11-13
- Kronos Bio, Inc. impairment lessor asset under operating lease for the quarter ending 2023-06-30 was $2.30M.
| Period end | Impairment Lessor Asset Under Operating Lease 3 month | Impairment Lessor Asset Under Operating Lease 9 month |
|---|---|---|
| 2023-09-30 | $2.30M 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $2.30M 10-Q · filed 2023-08-08 |